Holdings in Company

RNS Number : 0266A

Oxford Biomedica PLC

28 January 2022

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BDFBVT43

Issuer Name

OXFORD BIOMEDICA PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An event changing the breakdown of voting

3. Details of person subject to the notification obligation

Name

Novo Holdings A/S

City of registered office (if applicable)

Hellerup

Country of registered office (if applicable)

Name	Cityofregisteredoffice	Countryofregisteredoffice
NovoNordiskFoundation	Hellerup	Denmark

4. Details of the shareholder

Name	Cityof registeredoffice	Countryofregisteredoffice
NovoHoldingsA/S	Hellerup	Denmark

5. Date on which the threshold was crossed or reached

01-Jun-2021

6. Date on which Issuer notified

27-Jan-2022

7. Total positions of person(s) subject to the notification obligation

	% of votingrights attachedtoshares(total of 8.A)	% of voting rightsthrough financialinstruments(total of8.B 1 +8.B2)	Total of bothin % (8.A +8.B)	Total numberof votingrights heldin issuer
Resultingsituationonthedateonwhich thresholdwas	9.570000	0.000000	9.570000	8253000
crossed or reached
Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type ofshares ISINcode(ifpossible)	Number of directvoting rights(DTR5.1)	Number ofindirectvoting rights(DTR5.2.1)	% of direct votingrights(DTR5.1)	% of indirectvoting rights(DTR5.2.1)
GB00BDFBVT43	8253000	0	9.570000	0.000000
SubTotal 8.A	8253000		9.570000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Typeoffinancialinstrument	Expirationdate	Exercise/conversionperiod	Number of voting rights thatmay be acquired if theinstrument isexercised/converted	% ofvotingrights
SubTotal 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type offinancialinstrument	Expirationdate	Exercise/conversionperiod	Physical or cashsettlement	Number ofvotingrights	% ofvotingrights
SubTotal 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

The position of Novo Holdings A/S in its previous TR-1 notification was 10.1%. This notification obligation has arisen as a result of issuances of shares by the issuer (and not a disposal of shares by Novo Holdings A/S) and is based upon the latest total voting rights announcement of the issuer dated 4 January 2022.

The qualifying instruments are held by Novo Holdings A/S, the holding company in the Novo Group. Novo Holdings A/S is wholly owned by the Novo Nordisk Foundation.

12. Date of Completion

27-Jan-2022

13. Place Of Completion

London, United Kingdom

Contact name:	Natalie Walter
Contact telephone number:	01865 783000

 

END

 

 

HOLEADFPALPAEFA